Literature DB >> 16585652

Prevalence and temporal stability of selected clostridial groups in irritable bowel syndrome in relation to predominant faecal bacteria.

Johanna Maukonen1, Reetta Satokari1, Jaana Mättö1, Hans Söderlund1, Tiina Mattila-Sandholm2, Maria Saarela1.   

Abstract

The differences in faecal bacterial population between irritable bowel syndrome (IBS) and control subjects have been reported in several studies. The aim of the present study was to compare the predominant and clostridial faecal microbiota of IBS subjects and healthy controls by applying denaturing gradient gel electrophoresis (DGGE) and a recently developed multiplexed and quantitative hybridization-based technique, transcript analysis with the aid of affinity capture (TRAC). According to the results, the studied clostridial groups (Clostridium histolyticum, Clostridium coccoides-Eubacterium rectale, Clostridium lituseburense and Clostridium leptum) represented the dominant faecal microbiota of most of the studied subjects, comprising altogether 29-87% of the total bacteria as determined by the hybridized 16S rRNA. The C. coccoides-E. rectale group was the dominant subgroup of clostridia, contributing a mean of 43% of the total bacteria in control subjects and 30% (constipation type) to 50% (diarrhoea type) in different IBS symptom category subjects. The proportion of the C. coccoides-E. rectale group was found to be significantly lower in the constipation-type IBS subjects than in the control subjects. DNA-based PCR-DGGE and RNA-based RT-PCR-DGGE analyses targeted to the predominant bacterial population showed considerable biodiversity as well as uniqueness of the microbiota in each subject, in both control and IBS subject groups. The RT-PCR-DGGE profiles of the IBS subjects further indicated higher instability of the bacterial population compared to the control subjects. The observations suggest that clostridial microbiota, in addition to the instability of the active predominant faecal bacterial population, may be involved in IBS.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16585652     DOI: 10.1099/jmm.0.46134-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  57 in total

Review 1.  Gut microbiota and related diseases: clinical features.

Authors:  Vincenzo Stanghellini; Giovanni Barbara; Cesare Cremon; Rosanna Cogliandro; Alexandra Antonucci; Veronica Gabusi; Chiara Frisoni; Roberto De Giorgio; Valentina Grasso; Mauro Serra; Roberto Corinaldesi
Journal:  Intern Emerg Med       Date:  2010-10       Impact factor: 3.397

2.  Do Patients with Functional Gastrointestinal Disorders have an Altered Gut Flora?

Authors:  Eamonn M M Quigley
Journal:  Therap Adv Gastroenterol       Date:  2009-07       Impact factor: 4.409

Review 3.  A Systematic Review of the Effects of Polyols on Gastrointestinal Health and Irritable Bowel Syndrome.

Authors:  Adrienne Lenhart; William D Chey
Journal:  Adv Nutr       Date:  2017-07-14       Impact factor: 8.701

Review 4.  Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions.

Authors:  Lena Ohman; Magnus Simrén
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-01-26       Impact factor: 46.802

Review 5.  Gut microbiota role in irritable bowel syndrome: New therapeutic strategies.

Authors:  Eleonora Distrutti; Lorenzo Monaldi; Patrizia Ricci; Stefano Fiorucci
Journal:  World J Gastroenterol       Date:  2016-02-21       Impact factor: 5.742

6.  Gut microbiota of healthy elderly NSAID users is selectively modified with the administration of Lactobacillus acidophilus NCFM and lactitol.

Authors:  Marika Björklund; Arthur C Ouwehand; Sofia D Forssten; Janne Nikkilä; Kirsti Tiihonen; Nina Rautonen; Sampo J Lahtinen
Journal:  Age (Dordr)       Date:  2011-08-19

7.  Diarrhoea-predominant irritable bowel syndrome distinguishable by 16S rRNA gene phylotype quantification.

Authors:  Anna Lyra; Teemu Rinttilä; Janne Nikkilä; Lotta Krogius-Kurikka; Kajsa Kajander; Erja Malinen; Jaana Mättö; Laura Mäkelä; Airi Palva
Journal:  World J Gastroenterol       Date:  2009-12-21       Impact factor: 5.742

8.  From cytokines to toll-like receptors and beyond - current knowledge and future research needs in irritable bowel syndrome.

Authors:  Oscar Rodríguez-Fandiño; Joselín Hernández-Ruiz; Max Schmulson
Journal:  J Neurogastroenterol Motil       Date:  2010-10-30       Impact factor: 4.924

9.  Sequence analysis of percent G+C fraction libraries of human faecal bacterial DNA reveals a high number of Actinobacteria.

Authors:  Lotta Krogius-Kurikka; Anna Kassinen; Lars Paulin; Jukka Corander; Harri Mäkivuokko; Jarno Tuimala; Airi Palva
Journal:  BMC Microbiol       Date:  2009-04-08       Impact factor: 3.605

10.  Microbial community analysis reveals high level phylogenetic alterations in the overall gastrointestinal microbiota of diarrhoea-predominant irritable bowel syndrome sufferers.

Authors:  Lotta Krogius-Kurikka; Anna Lyra; Erja Malinen; Johannes Aarnikunnas; Jarno Tuimala; Lars Paulin; Harri Mäkivuokko; Kajsa Kajander; Airi Palva
Journal:  BMC Gastroenterol       Date:  2009-12-17       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.